Literature DB >> 20426400

Alpha-arylation of 3-aryloxindoles.

Cheng-Kang Mai1, Matthew F Sammons, Tarek Sammakia.   

Abstract

A versatile method for the synthesis of 3,3-diaryloxindoles via Pd-catalyzed alpha-arylations or an S(N)Ar reaction is described. The reaction proceeds using mild base, is tolerant of a variety of functional groups, and is capable of preparing hindered all-carbon quaternary centers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20426400      PMCID: PMC2896240          DOI: 10.1021/ol100666v

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  33 in total

1.  The second total synthesis of diazonamide A.

Authors:  K C Nicolaou; Paraselli Bheema Rao; Junliang Hao; Mali Venkat Reddy; Gerasimos Rassias; Xianhai Huang; David Y-K Chen; Scott A Snyder
Journal:  Angew Chem Int Ed Engl       Date:  2003-04-17       Impact factor: 15.336

2.  Chemistry and biology of diazonamide A: first total synthesis and confirmation of the true structure.

Authors:  K C Nicolaou; David Y-K Chen; Xianhai Huang; Taotao Ling; Marco Bella; Scott A Snyder
Journal:  J Am Chem Soc       Date:  2004-10-13       Impact factor: 15.419

3.  Syntheses and antiproliferative evaluation of oxyphenisatin derivatives.

Authors:  Muhammed K Uddin; Serge G Reignier; Tom Coulter; Christian Montalbetti; Charlotta Grånäs; Steven Butcher; Christian Krog-Jensen; Jakob Felding
Journal:  Bioorg Med Chem Lett       Date:  2007-02-25       Impact factor: 2.823

Review 4.  It all began with an error: the nomofungin/communesin story.

Authors:  Peter Siengalewicz; Tanja Gaich; Johann Mulzer
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

5.  Matching the chirality of monodentate N-heterocyclic carbene ligands: a case study on well-defined palladium complexes for the asymmetric alpha-arylation of amides.

Authors:  Xinjun Luan; Ronaldo Mariz; Carine Robert; Michele Gatti; Sascha Blumentritt; Anthony Linden; Reto Dorta
Journal:  Org Lett       Date:  2008-12-18       Impact factor: 6.005

6.  Transition metal-catalyzed direct arylation of substrates with activated sp3-hybridized C-H bonds and some of their synthetic equivalents with aryl halides and pseudohalides.

Authors:  Fabio Bellina; Renzo Rossi
Journal:  Chem Rev       Date:  2010-02-10       Impact factor: 60.622

7.  Enantioselective alpha-arylation of ketones with aryl triflates catalyzed by difluorphos complexes of palladium and nickel.

Authors:  Xuebin Liao; Zhiqiang Weng; John F Hartwig
Journal:  J Am Chem Soc       Date:  2007-12-13       Impact factor: 15.419

Review 8.  Pyrrolidinyl-spirooxindole natural products as inspirations for the development of potential therapeutic agents.

Authors:  Chris V Galliford; Karl A Scheidt
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

9.  Palladium-catalyzed enantioselective alpha-arylation and alpha-vinylation of oxindoles facilitated by an axially chiral P-stereogenic ligand.

Authors:  Alexander M Taylor; Ryan A Altman; Stephen L Buchwald
Journal:  J Am Chem Soc       Date:  2009-07-29       Impact factor: 15.419

10.  Palladium-catalyzed alpha-arylation of oxindoles.

Authors:  Matthew J Durbin; Michael C Willis
Journal:  Org Lett       Date:  2008-03-06       Impact factor: 6.005

View more
  3 in total

1.  Preparation of Aryl-Susbstituted 2-Oxyindoles by Superelectrophilic Chemistry.

Authors:  Rajasekhar Reddy Naredla; Erum K Raja; Douglas A Klumpp
Journal:  Tetrahedron Lett       Date:  2013-06-19       Impact factor: 2.415

2.  Organocatalytic asymmetric Michael addition of unprotected 3-substituted oxindoles to 1,4-naphthoquinone.

Authors:  Jin-Sheng Yu; Feng Zhou; Yun-Lin Liu; Jian Zhou
Journal:  Beilstein J Org Chem       Date:  2012-08-23       Impact factor: 2.883

3.  Efficient synthesis of 3H-indoles enabled by the lead-mediated α-arylation of β-ketoesters or γ-lactams using aryl azides.

Authors:  Fei Zhou; Tom G Driver
Journal:  Org Lett       Date:  2014-05-27       Impact factor: 6.005

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.